Pharmacological shift of the ambiguous nitric oxide action from neurotoxicity to cyclic GMP-mediated protection.
about
Getting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric OxideNeuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease.Phosphodiesterase inhibitors as therapeutics for traumatic brain injury.SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions.Argininosuccinic aciduria fosters neuronal nitrosative stress reversed by Asl gene transfer
P2860
Pharmacological shift of the ambiguous nitric oxide action from neurotoxicity to cyclic GMP-mediated protection.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Pharmacological shift of the a ...... yclic GMP-mediated protection.
@en
Pharmacological shift of the a ...... yclic GMP-mediated protection.
@nl
type
label
Pharmacological shift of the a ...... yclic GMP-mediated protection.
@en
Pharmacological shift of the a ...... yclic GMP-mediated protection.
@nl
prefLabel
Pharmacological shift of the a ...... yclic GMP-mediated protection.
@en
Pharmacological shift of the a ...... yclic GMP-mediated protection.
@nl
P2093
P2860
P1476
Pharmacological shift of the a ...... yclic GMP-mediated protection.
@en
P2093
Haruyasu Yamamoto
Peter Schubert
Shigeru Kohgami
Tadanori Ogata
Tadao Morino
P2860
P304
P356
10.1179/016164110X12681290831243
P577
2010-04-27T00:00:00Z